Medicinal products for gene therapy: Onasemnogen abeparvovec
Status
Active
Submission Deadline
35 days remaining
Contracting authority
SPITALUL CLINIC DE PEDIATRIE SIBIU1 more open tender view
Location
Sibiu, Romania
Procedure
Open Procedure · Supplies
Category
Medicinal products for the nervous system.
Published
Reference
ted-563586-2026
Source
Supply of the gene therapy drug Onasemnogen abeparvovec: for the treatment of patients with Spinal Muscular Atrophy (SMA) under the National Health Program for Rare Diseases. The treatment consists of a single dose. Orders are placed after diagnosis and funding approval from the Sibiu County Health Insurance House, limited by funds from the National Health Program for Rare Diseases, Subprogram Spinal Muscular Atrophy. The drug kit is customized per patient according to weight. Product details as per the tender specifications.
Free
Never miss a tender again
We send you 3 current matches that fit your company.
Tender documents
- Portal — LOT-0000NON-RESTRICTED-DOCUMENT
- TED HTML — 563586-2026HTML
- TED PDF — 563586-2026PDF
- TED XML — 563586-2026XML
Free
Unlock documents for free
Enter your email address. If you confirm, we will also send you 3 similar tenders.
Additional details
EU Funded
Yes
Electronic Submission
Required
Legal Basis
32014L0024